Navigation Links
Novel mechanism of action of new drug for MS identified

Virginia Commonwealth University researchers have identified a unique mechanism of action of a new drug that shows great promise for the treatment of multiple sclerosis.

The researchers report the unique action of FTY720, or Fingolimod, an immunosuppressant drug that was already known to affect the functioning of the immune system by preventing the egress of white blood cells from the lymph nodes into the blood. The article was pre-published as a First Edition Paper in Blood, The Journal of the American Society of Hematology, which appeared online on Sept. 28.

In this study, the research team observed that FTY720 also inhibited the activity of a key enzyme called cPLA2, which is necessary for the production of inflammatory mediators, known as eicosanoids. Eicosanoids drive inflammatory disorders such as asthma and multiple sclerosis.

According to Sarah Spiegel, Ph.D., professor and chair in the VCU Department of Biochemistry, and lead author on the study, the inhibition of cPLA2 would shut down the entire inflammatory pathway, possibly without the side-effects caused by medications such as Vioxx, that have been withdrawn from the pharmaceutical market.

FTY720, a drug developed by Novartis, has shown considerable therapeutic effects in a recent small, placebo-controlled clinical trial involving patients with relapsing multiple sclerosis. The study was published in the September 2006 issue of the New England Journal of Medicine by an international research team. With its novel mode of action and the added benefit of an oral formulation, further clinical development of FTY720 might have a major impact on treatment of MS, said Spiegel.

"By clearly understanding the mechanism of action of drugs such as FTY720, we can develop more optimal treatments for inflammatory disease such as asthma or MS. This drug may prevent both inflammation and axonal damage, including demyelination, which are characteristic of MS," said Spiegel.


'"/>

Source:Virginia Commonwealth University


Page: 1 2

Related biology news :

1. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
2. Novel technology detects human DNA mutations
3. Novel antiviral technology inhibits RSV infection in mice
4. Novel Enzyme Shows Potential As An Anti-HIV Target
5. Novel Therapy Tested in Mice Could Chase Away Cat Allergies
6. Discovery Could Lead To Novel Approaches In HIV Treatment
7. Novel ultrafast laser detection of cancer cells also may improve understanding of stem cells
8. Research Using Mouse Models Reveals A Novel Key Player In The Initiation Of Colon Cancer
9. Novel gene-silencing nanoparticles shown to inhibit Ewings sarcoma
10. Novel live reporting system to track cells
11. Field of beams - Novel system uses polarized light pulses to reveal crop health
Post Your Comments:
(Date:12/14/2009)... part of an international team that has used DNA ... the history of North America,s woolly mammoths and ancient ... and Atmospheric Sciences professor Duane Froese and his colleagues ... of bones and teeth. That analysis concluded that more ... (the ,megafauna,) disappeared about 13,000 years ago. , ...
(Date:12/14/2009)... Researchers at Rice University and Baylor College of Medicine ... tracked in real time with MRI as it homes ... dye and kills them with heat. The all-in-one particle ... field called "theranostics" that develops technologies physicians can use ... , The research is available online in the journal ...
(Date:12/14/2009)... novel antifreeze molecule in a freeze-tolerant Alaska beetle able ... all previously described biological antifreezes that contain protein, this ... It is composed of a sugar and a fatty ... cells of organisms. , "The most exciting part ... whole new kind of antifreeze that may work in ...
Breaking Biology News(10 mins):Tracking new cancer-killing particles with MRI 2Scientists isolate new antifreeze molecule in Alaska beetle 2Sundia and 2 Other CRO Companies Granted Express Customs Clearance Privilege in Shanghai 12779 1Sundia and 2 Other CRO Companies Granted Express Customs Clearance Privilege in Shanghai 12779 2Sundia and 2 Other CRO Companies Granted Express Customs Clearance Privilege in Shanghai 12779 3Egglands Best and Award Winning Fitness Trainer Cathe Friedrich Launch National Health and Fitness Program 50008 1Egglands Best and Award Winning Fitness Trainer Cathe Friedrich Launch National Health and Fitness Program 50008 2Egglands Best and Award Winning Fitness Trainer Cathe Friedrich Launch National Health and Fitness Program 50008 3Egglands Best and Award Winning Fitness Trainer Cathe Friedrich Launch National Health and Fitness Program 50008 4New Study Shows that Prebiotics as Used by Jackson GI Medical Increases Lifespan by 33 25 50006 1New Study Shows that Prebiotics as Used by Jackson GI Medical Increases Lifespan by 33 25 50006 2
... space shuttle Endeavour lifts off this month, its flight ... built by the University of Alabama at Birmingham (UAB). ... cryogenic freezers from the UAB Center for Biophysical Sciences ... capacity of the shuttle and the International Space Station ...
... University of Texas at Austin, will present new research ... Control Technologies that examines a unique storage method in ... via buoyancy. , When: Nov. 19, about 9:30-10 a.m. ... NW, in Washington, D.C. The research will be presented ...
... CAMBRIDGE, Mass. -- Researchers at MIT,s Center for Energy ... key design issues of proposed "cap-and-trade" programs that are ... of curbing greenhouse gas emissions. The first contribution of ... of the European Union,s system and of similar U.S. ...
Other Biology News:Compact research freezers to debut in space 2Engineer to present leak-proof method for carbon dioxide storage at international conference 2MIT analysis shows how cap-and-trade plans can cut greenhouse emissions 2
(Date:12/14/2009)... and THOUSAND OAKS, Calif., Dec. 14 ... Amgen Inc.(Nasdaq: AMGN ) today announced that ... worldwide rights to Array,s small-molecule glucokinase activator program, ... 1 clinical trial in patients with Type 2 ... the agreement, Array will receive an upfront payment ...
(Date:12/14/2009)... Dec. 14 Vermillion, Inc. (Pink ... announced William C. Wallen, Ph.D. Chief Scientific ... for IDEXX Laboratories, will be joining its ... bankruptcy plan. ,, "Bill brings more ... in diagnostics and biotechnology," said Gail Page, ...
(Date:12/14/2009)... Dec. 14 Dyadic International, Inc. (Pink ... extended its collaboration with The Scripps Research Institute ... to re-annotate the genome of Dyadic,s patented and ... a continuation of the successful relationship between the ... Dyadic engaged Scripps to annotate the C1 genome ...
(Date:12/14/2009)... Biotech Leaders to Develop Blueprint to Preserve ... Boosting Rhode Island,s Growing Biotech and Medical ... 14 Several of Rhode Island,s ... biotechnology gathered today at Brown University,s Medical ... medical innovation in Rhode Island and throughout ...
Breaking Biology Technology:Array BioPharma and Amgen Partner in Type 2 Diabetes 2Array BioPharma and Amgen Partner in Type 2 Diabetes 3Array BioPharma and Amgen Partner in Type 2 Diabetes 4Array BioPharma and Amgen Partner in Type 2 Diabetes 5Array BioPharma and Amgen Partner in Type 2 Diabetes 6Array BioPharma and Amgen Partner in Type 2 Diabetes 7Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 2Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 3Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 4
... Campbell Alliance, the leading,management consulting firm specializing in ... was recognized as one of the best,places to work ... by the,Triangle Business Journal, ranking third among midsize companies. ... Business Journal,s annual Best,Places to Work luncheon and awards ...
... LOS ANGELES, Oct. 10 Signalife has received,additional sales ... to,be exact), during CEO Lowell Harmison,s most recent cross-country ... to,the company such that the company anticipates achieving break-even ... very latest the end of 2008 first,quarter. About ...
... Want to Double our Sales Within Three Years", ... of EUR 3.4 million to EUR 17 million, Dr. ... path of significant growth in 2007. "We want to ... states CEO Nikolaus Uleer.,With the construction of the largest ...
Other Biology Technology:Campbell Alliance Named 'Best Place to Work' by Triangle Business Journal 2Signalife Continues to Procure Purchase Orders, Revenues 2Dr. Suwelack Skin & Health Care: New Product in the FDA Certification Process 2
One controller two vessel system suitable for early stage of fermentation, and small scale, Application : cultivation of microorganisms and human or animal cells...
... space and organize gloves, safety glasses, ... are the perfect benchtop storage bins ... processing and manufacturing. Clear static-dissipative PVC ... they attract. Many other sizes and ...
... generation of the popular precision current ... iontophoresis of neural transport tracers such ... amino acids into neural tissue, is ... also be used to make small ...
... Thermostable dUTPase The ... of high-fidelity PCR (using proofreading DNA ... present in PCR reactions and dNTP ... in a proofreading DNA polymerase reaction ...
Biology Products: